202 related articles for article (PubMed ID: 36350258)
1. Prevalence of aldosterone breakthrough in dogs receiving renin-angiotensin system inhibitors for proteinuric chronic kidney disease.
Ames MK; Vaden SL; Atkins CE; Palerme JS; Langston CE; Grauer GF; Shropshire S; Bove C; Webb T
J Vet Intern Med; 2022 Nov; 36(6):2088-2097. PubMed ID: 36350258
[TBL] [Abstract][Full Text] [Related]
2. Aldosterone breakthrough in dogs with naturally occurring myxomatous mitral valve disease.
Ames MK; Atkins CE; Eriksson A; Hess AM
J Vet Cardiol; 2017 Jun; 19(3):218-227. PubMed ID: 28576479
[TBL] [Abstract][Full Text] [Related]
3. Effects of telmisartan on proteinuria and systolic blood pressure in dogs with chronic kidney disease.
Miyagawa Y; Akabane R; Sakatani A; Ogawa M; Nagakawa M; Miyakawa H; Takemura N
Res Vet Sci; 2020 Dec; 133():150-156. PubMed ID: 32992126
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of telmisartan for the treatment of persistent renal proteinuria in dogs: A double-masked, randomized clinical trial.
Lourenço BN; Coleman AE; Brown SA; Schmiedt CW; Parkanzky MC; Creevy KE
J Vet Intern Med; 2020 Nov; 34(6):2478-2496. PubMed ID: 33165969
[TBL] [Abstract][Full Text] [Related]
5. Effects of dual blockade of the renin-angiotensin system in primary proteinuric nephropathies.
Luño J; Barrio V; Goicoechea MA; González C; de Vinuesa SG; Gómez F; Bernis C; Espinosa M; Ahijado F; Gómez J; Escalada P
Kidney Int Suppl; 2002 Dec; (82):S47-52. PubMed ID: 12410855
[TBL] [Abstract][Full Text] [Related]
6. Renin-angiotensin system inhibitors in proteinuric chronic kidney disease.
Hirsch S
Compr Ther; 2009; 35(2):91-5. PubMed ID: 19618757
[TBL] [Abstract][Full Text] [Related]
7. The circulating renin-angiotensin-aldosterone system is down-regulated in dogs with glomerular diseases compared to other chronic kidney diseases with low-grade proteinuria.
Grandt LM; Schweighauser A; Kovacevic A; Francey T
PLoS One; 2022; 17(1):e0262121. PubMed ID: 35007295
[TBL] [Abstract][Full Text] [Related]
8. Effect of calcifediol supplementation on renin-angiotensin-aldosterone system mediators in dogs with chronic kidney disease.
Miller M; Quimby J; Langston C; Ames M; Parker VJ
J Vet Intern Med; 2022 Sep; 36(5):1693-1699. PubMed ID: 35962709
[TBL] [Abstract][Full Text] [Related]
9. Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease.
Bianchi S; Bigazzi R; Campese VM
Kidney Int; 2006 Dec; 70(12):2116-23. PubMed ID: 17035949
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the effects of a therapeutic renal diet to control proteinuria in proteinuric non-azotemic dogs treated with benazepril.
Cortadellas O; Talavera J; Fernández del Palacio MJ
J Vet Intern Med; 2014; 28(1):30-7. PubMed ID: 24372810
[TBL] [Abstract][Full Text] [Related]
11. Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease.
Chung EY; Ruospo M; Natale P; Bolignano D; Navaneethan SD; Palmer SC; Strippoli GF
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD007004. PubMed ID: 33107592
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the progression of non-azotemic proteinuric chronic kidney disease in dogs.
Miyakawa H; Ogawa M; Sakatani A; Akabane R; Miyagawa Y; Takemura N
Res Vet Sci; 2021 Sep; 138():11-18. PubMed ID: 34090202
[TBL] [Abstract][Full Text] [Related]
13. Beneficial long-term effect of aldosterone antagonist added to a traditional blockade of the renin-angiotensin-aldosterone system among patients with obesity and proteinuria.
Morales E; Gutiérrez E; Caro J; Sevillano A; Rojas-Rivera J; Praga M
Nefrologia; 2015; 35(6):554-61. PubMed ID: 26519114
[TBL] [Abstract][Full Text] [Related]
14. Aldosterone breakthrough during aliskiren, valsartan, and combination (aliskiren + valsartan) therapy.
Bomback AS; Rekhtman Y; Klemmer PJ; Canetta PA; Radhakrishnan J; Appel GB
J Am Soc Hypertens; 2012; 6(5):338-45. PubMed ID: 22995802
[TBL] [Abstract][Full Text] [Related]
15. Effect of telmisartan, angiotensin-converting enzyme inhibition, or both, on proteinuria and blood pressure in dogs.
Fowler BL; Stefanovski D; Hess RS; McGonigle K
J Vet Intern Med; 2021 May; 35(3):1231-1237. PubMed ID: 33769606
[TBL] [Abstract][Full Text] [Related]
16. Treatment of proteinuria in dogs with telmisartan: A retrospective study.
Lecavalier J; Fifle L; Javard R
J Vet Intern Med; 2021 Jul; 35(4):1810-1818. PubMed ID: 33969924
[TBL] [Abstract][Full Text] [Related]
17. The classical and alternative circulating renin-angiotensin system in normal dogs and dogs with stage B1 and B2 myxomatous mitral valve disease.
Hammond HH; Ames MK; Domenig O; Scansen BA; Yang NT; Wilson MD; Sunshine E; Brunk K; Masters A
J Vet Intern Med; 2023; 37(3):875-886. PubMed ID: 36951394
[TBL] [Abstract][Full Text] [Related]
18. Aliskiren add-on therapy effectively reduces proteinuria in chronic kidney disease: an open-label prospective trial.
Wu MT; Tung SC; Hsu KT; Lee CT
J Renin Angiotensin Aldosterone Syst; 2014 Sep; 15(3):271-7. PubMed ID: 23223162
[TBL] [Abstract][Full Text] [Related]
19. Management of Proteinuria in Dogs and Cats with Chronic Kidney Disease.
Vaden SL; Elliott J
Vet Clin North Am Small Anim Pract; 2016 Nov; 46(6):1115-30. PubMed ID: 27485278
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast growth factor 23 and the antiproteinuric response to dietary sodium restriction during renin-angiotensin-aldosterone system blockade.
Humalda JK; Lambers Heerspink HJ; Kwakernaak AJ; Slagman MC; Waanders F; Vervloet MG; Ter Wee PM; Navis G; de Borst MH;
Am J Kidney Dis; 2015 Feb; 65(2):259-66. PubMed ID: 25278093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
